SB1290 would create a new warning-label requirement for certain foods and products sold or distributed in Hawaii that are considered carcinogenic. Beginning July 1, 2027, covered items would have to bear a label warning of any known risk of cancer, birth defects, or reproductive harm associated with exposure to the product. The bill directs the Department of Health to adopt rules establishing the format and contents of the labels.
The bill defines “carcinogenic” by reference to the World Health Organization’s International Agency for Research on Cancer, covering items or chemicals classified as Group 1 or Group 2A. It also includes an appropriation for the Department of Health to implement and enforce the new labeling program, with funding requested for fiscal years 2025-2026 and 2026-2027. Although the act would take effect July 1, 2025, the labeling mandate itself would not begin until July 1, 2027.
Impact
SB1290 would add a new section to Chapter 328 of the Hawaii Revised Statutes and expand state food and product safety regulation by requiring warning labels on certain carcinogenic foods and products. It would also give the Department of Health rulemaking authority over label format and content and provide appropriated funds for implementation and enforcement. The bill could affect manufacturers, distributors, and retailers of covered products, as well as consumers who would see new health warnings at the point of sale.
Sentiment
Based on the available record, there is no committee transcript or vote history showing formal support or opposition, so the overall sentiment cannot be measured from debate or roll calls. The bill’s framing suggests a public-health-oriented approach focused on consumer warning and risk disclosure. Because no discussion or votes are available, there is no documented consensus or controversy in the provided materials.
Contention
The main likely points of contention are the breadth of the definition of “carcinogenic,” which relies on IARC Group 1 and 2A classifications, and the practical burden on businesses that would need to identify covered products and comply with labeling rules. Another possible issue is the scope of the warning requirement, since it applies to any food or product sold or distributed in the state and could reach a wide range of consumer goods. The bill also leaves the appropriation amount blank, which may raise questions about implementation costs and enforcement capacity for the Department of Health.